David Tuller

Trial By Error: Just the Latest Gibberish from Professor Chalder

By David Tuller, DrPH I’ve said it before and will undoubtedly say it again. Trudie Chalder, King’s College London’s mathematically and factually challenged professor of cognitive behavior therapy (CBT), is a one-trick pony. She writes what is essentially the same bad paper based on the same unfounded assumptions over and ...

Trial By Error: Professor Chris Ponting Discusses on DecodeME’s First Results

By David Tuller, DrPHProfessor Chris Ponting is a geneticist at the University of Edinburgh. He is also the principal investigator for DecodeME, a genome wide association study. The DecodeME team recently published findings from more than 17,000 questionnaires it had collected from patients. I wrote about those findings in a ...

Trial By Error: DecodeME Team Describes Study Sample; The Atlantic’s Ed Yong Covers PEM; STAT Busts NIH’s Stumbling Long Covid Efforts

By David Tuller, DrPH Update: The post indicates that more than 17,000 people had submitted the DecodeME questionnaire. Actually, as of the most recent count this month, DecodeME has now received more than 23,000 questionnaires. DecodeME paper finds ME/CFS severity linked to being female, being older and being sick longer ...

Trial By Error: Rapid Response to Anti-NICE Whine de Coeur; UK Government Seeks Input to Interim Delivery Plan for ME/CFS

By David Tuller, DrPH The Journal of Neurology, Neurosurgery, and Psychiatry (JNNP) has finally published a cogent rapid response to its recent whine de coeur from the PACE authors and their cronies. In the commentary, the co-authors criticized eight purported "anomalies" they believe occurred during the process of developing the ...

Trial By Error: More on the Perplexing Dutch Claim that Null Results for Objective Measures of Physical Activity Are Irrelevant to Fatigue

By David Tuller, DrPH I recently wrote about a Dutch study published a few months ago in the journal Clinical Infectious Diseases--“Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial.” The study, nick-named ReCOVer, found that unblinded trials relying on subjective outcomes ...
Scroll to Top